Spots Global Cancer Trial Database for regn6569
Every month we try and update this database with for regn6569 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies | NCT04465487 | Squamous Cell C... | REGN6569 Cemiplimab | 18 Years - | Regeneron Pharmaceuticals |